Lamotrigine

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Lamotrigine and local guidelines before prescribing.

Anticonvulsant

Mechanism

Blocks voltage-gated sodium channels and glutamate release.

Uses

Epilepsy (focal and generalised), bipolar disorder maintenance.

Dosing

3 more dose entries from the chapters
  • Epilepsy — lamotrigine and levetiracetam preferred; folic acid 5 mg; never stop AEDs abruptly; vitamin K is no longer routinely given to mothers.
    Obstetrics
  • Epilepsy | Lamotrigine or levetiracetam ; folic acid 5 mg; avoid valproate
    Clinical pharmacology and prescribing: Prescribing in special groups
  • … risk of neurodevelopmental disorders. Under the Pregnancy Prevention Programme, she should have urgent specialist review to switch to a safer antiepileptic (e.g. lamotrigine or levetiracetam) before conception, and take folic acid 5 mg daily.
    Anatomy: Embryology and development

Side effects

Rash (including Stevens-Johnson), dizziness, headache, diplopia, tremor.

Interactions

Valproate more than doubles levels (halve dose); enzyme inducers halve levels; oestrogen contraceptives lower levels.

Contraindications and cautions

Rash history with lamotrigine

Monitoring

Rash, mood

Pregnancy and breastfeeding

Preferred anticonvulsant in pregnancy; levels fall

Renal and hepatic impairment

Reduce dose in moderate to severe liver impairment

Overdose and reversal

Supportive; ECG

Special advice

Titrate slowly to reduce rash risk; stop at any rash with fever; restart titration if missed for more than 5 half-lives.

More from the textbook: uses, cautions and other points
Where it is discussed in the book